Definition of fibromyalgia severity: findings from a cross-sectional survey of 2339 Italian patients

Author:

Salaffi Fausto1ORCID,Di Carlo Marco1ORCID,Bazzichi Laura2,Atzeni Fabiola3ORCID,Govoni Marcello4,Biasi Giovanni5,Di Franco Manuela6,Mozzani Flavio7,Gremese Elisa8,Dagna Lorenzo9,Batticciotto Alberto10,Fischetti Fabio11,Giacomelli Roberto12,Guiducci Serena13,Guggino Giuliana14ORCID,Bentivegna Mario15,Gerli Roberto16ORCID,Salvarani Carlo17,Bajocchi Gianluigi18,Ghini Marco19,Iannone Florenzo20ORCID,Giorgi Valeria21,Farah Sonia1ORCID,Cirillo Mariateresa3,Bonazza Sara4,Barbagli Stefano5,Gioia Chiara6,Santilli Daniele7,Capacci Annunziata8,Cavalli Giulio9,Carubbi Francesco12,Nacci Francesca13,Riccucci Ilenia16,Sinigaglia Luigi22,Masullo Maurizio23,Polizzi Bianca Maria23,Cutolo Maurizio24,Sarzi-Puttini Piercarlo21ORCID

Affiliation:

1. Rheumatology Clinic, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Jesi (Ancona), Italy

2. Rheumatology Unit, AOU Pisana, Pisa, Italy

3. Rheumatology Unit, Department of Internal Medicine, University of Messina, Messina, Italy

4. Rheumatology, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliera–Universitaria di Ferrara, Ferrara, Italy

5. Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy

6. Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences Rheumatology Unit- Policlinico Umberto I, Sapienza University of Rome, Rome, Italy

7. Internal Medicine and Rheumatology Unit, Azienda Ospedaliero–Universitaria di Parma, Parma, Italy

8. UOC Reumatologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

9. Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Milan, Italy

10. Rheumatology Unit, Internal Medicine Department, ASST Settelaghi, Ospedale Di Circolo - Fondazione Macchi, Varese, Italy

11. Department of Medical Sciences, University of Trieste, UCO Medicina Clinica (SSD Reumatologia), Trieste, Italy

12. Clinical Unit of Rheumatology, School of Medicine, University of L’Aquila, L’Aquila, Italy

13. Department of Experimental and Clinical Medicine, Divisions of Internal Medicine and Rheumatology AOUC, University of Florence, Florence, Italy

14. Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy

15. Integrated Reference Center of Rheumatology, ASP 7, Scicli Hospital, Ragusa, Italy

16. Rheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy

17. University of Modena and Reggio Emilia, Azienda USL-IRCCS di Reggio Emilia, Modena, Italy

18. Rheumatology Unit, S. Maria Hospital–USL, IRCCS Institute, Reggio Emilia, Italy

19. Rheumatology Unit, Azienda USL di Modena, Modena, Italy

20. Rheumatology Unit, Department of Emergency and Organ Transpantations, University of Bari, Bari, Italy

21. Rheumatology Unit, Internal Medicine Department, ASST Fatebenefratelli-Sacco, Milan State University School of Medicine, Milan, Italy

22. Division of Rheumatology, ASST Gaetano Pini–CTO, Milan, Italy

23. Ministry of Health, General Directorate of Health Care, Rome, Italy

24. Research Laboratory and Division of Clinical Rheumatology, Department of Internal Medicine, IRCCS San Martino, University of Genova, Genova, Italy

Abstract

Abstract Objective To establish optimal cut-off values for the scores of the revised Fibromyalgia Impact Questionnaire (FIQR), the modified Fibromialgia Assessment Scale (FAS 2019mod), and the Polysymptomatic Distress Scale (PDS) in order to distinguish five levels of FM disease severity. Methods Consecutive FM patients were evaluated with the three clinimetric indices, and each patient was required to answer the anchor question: ‘In general, would you say your health is 1 = very good, 2 = good, 3 = fair, 4 = poor, or 5 = very poor?’—which represented the external criterion. Cut-off points were established through the interquartile reconciliation approach. Results The study sample consisted of 2181 women (93.2%) and 158 men (6.8%), with a mean age of 51.9 (11.5) years, and mean disease duration was 7.3 (6.9) years. The overall median FIQR, FAS 2019 mod and PDS scores (25th–75th percentiles) were respectively 61.16 (41.16–77.00), 27.00 (19.00–32.00) and 19.0 (13.00–24.00). Reconciliation of the mean 75th and 25th percentiles of adjacent categories defined the severity states for FIQR: 0–23 for remission, 24–40 for mild disease, 41–63 for moderate disease, 64–82 for severe disease and >83 for very severe disease; FAS 2019 mod: 0–12 for remission, 13–20 for mild disease, 21–28 for moderate disease, 29–33 for severe disease and >33 for very severe disease; PDS: 0–5 for remission, 6–15 for mild disease, 16–20 for moderate disease, 21–25 for severe disease and >25 for very severe disease. Conclusions Disease severity cut-offs can represent an important improvement in interpreting FM.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Reference36 articles.

1. MArche Pain Prevalence; INvestigation Group (MAPPING) study. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study;Salaffi;Clin Exp Rheumatol,2005

2. Identifying the symptom and functional domains in patients with fibromyalgia: results of a cross-sectional Internet-based survey in Italy;Salaffi;J Pain Res,2016

3. Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises;Mease;Arthritis Rheum,2008

4. Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey;Salaffi;Clin Exp Rheumatol,2009

5. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss;White;J Occup Environ Med,2008

Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3